Cue Biopharma Inc RPE
What is the RPE of Cue Biopharma Inc?
The RPE of Cue Biopharma Inc is $169.306k
What is the definition of RPE?
Revenue per employee (RPE) is revenue divided by the number of employees of an organization.
= net income / number of employees
RPE of companies in the Health Care sector on NASDAQ compared to Cue Biopharma Inc
What does Cue Biopharma Inc do?
cue biopharma is an innovative immunotherapy company developing a novel, proprietary class of biologics engineered to selectively modulate the human immune system to treat a broad range of cancers and autoimmune disorders. we design biologics to engage and modulate the activity of disease-associated t cells in the patient’s body, offering significant therapeutic advantages while potentially minimizing or eliminating unwanted side effects. we believe our biologics allow us to target antigen-specific t cell populations in a variety of indications using a simple peptide exchange within previously-validated drug frameworks developed from the cue biologics platform. this flexibility could truncate the drug selection and development process, moving effective therapeutics from discovery to clinical validation more rapidly and cost efficiently than current industry standard timelines and costs. headquartered in kendall square, cambridge, ma, we are led by an experienced management team and sci
Companies with rpe similar to Cue Biopharma Inc
- IPG Photonics Corp has RPE of $168.685k
- TJX Companies has RPE of $169.067k
- WH Smith Plc has RPE of £169.091k
- Hydrix has RPE of AUD$169.143k
- Fidelity National Information Services has RPE of $169.154k
- Technologies has RPE of AUD$169.172k
- Cue Biopharma Inc has RPE of $169.306k
- FNM S.p.A has RPE of €169.307k
- BD Multimedia SA has RPE of €169.333k
- INDUS AG has RPE of €169.339k
- Gerresheimer AG has RPE of €169.486k
- Pearson plc has RPE of £169.508k
- Maisons du Monde S.A has RPE of €169.520k